DZ2563A1 - Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor. - Google Patents

Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor.

Info

Publication number
DZ2563A1
DZ2563A1 DZ980173A DZ980173A DZ2563A1 DZ 2563 A1 DZ2563 A1 DZ 2563A1 DZ 980173 A DZ980173 A DZ 980173A DZ 980173 A DZ980173 A DZ 980173A DZ 2563 A1 DZ2563 A1 DZ 2563A1
Authority
DZ
Algeria
Prior art keywords
insulin
hyperglycerinic
biguanide
alpha
composition containing
Prior art date
Application number
DZ980173A
Other languages
French (fr)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2563A1 publication Critical patent/DZ2563A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DZ980173A 1997-07-18 1998-07-15 Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor. DZ2563A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
DZ2563A1 true DZ2563A1 (en) 2003-02-15

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980173A DZ2563A1 (en) 1997-07-18 1998-07-15 Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor.

Country Status (27)

Country Link
EP (1) EP1001784A1 (en)
JP (1) JP2001510160A (en)
KR (1) KR20010021952A (en)
CN (1) CN1263467A (en)
AP (1) AP2000001735A0 (en)
AR (2) AR016350A1 (en)
AU (1) AU8449098A (en)
BG (1) BG104062A (en)
BR (1) BR9810292A (en)
CA (1) CA2297133A1 (en)
CO (1) CO4940489A1 (en)
DZ (1) DZ2563A1 (en)
EA (1) EA200000140A1 (en)
GB (1) GB9715298D0 (en)
HU (1) HUP0003626A3 (en)
ID (1) ID23804A (en)
IL (1) IL133907A0 (en)
MA (1) MA24608A1 (en)
NO (1) NO20000230D0 (en)
OA (1) OA11312A (en)
PE (1) PE99499A1 (en)
PL (1) PL338140A1 (en)
SK (1) SK612000A3 (en)
TR (1) TR200000133T2 (en)
UY (1) UY25101A1 (en)
WO (1) WO1999003478A1 (en)
ZA (1) ZA986364B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP1133312B8 (en) * 1999-06-21 2007-10-17 Eli Lilly And Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
DE60124861T2 (en) * 2000-01-21 2007-05-10 Novartis Ag COMPOSITIONS CONTAINING DIPEPTIDYLPEPTIDASE-IV INHIBITORS AND ANTIDIABETICA
US20030040490A1 (en) * 2000-02-24 2003-02-27 Yasuo Sugiyama Drugs containing combined active ingredients
JP4917712B2 (en) * 2000-02-24 2012-04-18 武田薬品工業株式会社 Concomitant medication
CA2725833A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
SI1677792T1 (en) 2003-10-31 2016-02-29 Takeda Pharmaceutical Company Limited Solid preparation comprising pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
TR200000133T2 (en) 2000-09-21
GB9715298D0 (en) 1997-09-24
MA24608A1 (en) 1999-04-01
JP2001510160A (en) 2001-07-31
AR019724A2 (en) 2002-03-13
ID23804A (en) 2000-05-11
NO20000230L (en) 2000-01-17
AP2000001735A0 (en) 2000-01-16
WO1999003478A1 (en) 1999-01-28
BG104062A (en) 2000-11-30
EA200000140A1 (en) 2000-06-26
CN1263467A (en) 2000-08-16
OA11312A (en) 2003-10-24
PL338140A1 (en) 2000-09-25
KR20010021952A (en) 2001-03-15
SK612000A3 (en) 2000-07-11
HUP0003626A3 (en) 2001-12-28
NO20000230D0 (en) 2000-01-17
ZA986364B (en) 2000-01-17
UY25101A1 (en) 2000-12-29
IL133907A0 (en) 2001-04-30
PE99499A1 (en) 1999-12-18
BR9810292A (en) 2000-09-19
HUP0003626A2 (en) 2001-05-28
CO4940489A1 (en) 2000-07-24
EP1001784A1 (en) 2000-05-24
AR016350A1 (en) 2001-07-04
CA2297133A1 (en) 1999-01-28
AU8449098A (en) 1999-02-10

Similar Documents

Publication Publication Date Title
DZ2562A1 (en) Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycemic biguanide.
NO20001602D0 (en) Business Agent
DE29880028U1 (en) Business card
BR9611184B8 (en) COMPOUND AND COMPOSITION.
NO990854L (en) Substituted N - [(aminiminomethyl or aminomethyl) phenyl] propylamides
EP0621714A3 (en) Information services platform.
DZ1912A1 (en) Heteroaryl-oxazolidinones containing nitrogen at 6members.
BR9504791B1 (en) polypeptide compound and pharmaceutical composition.
DZ2563A1 (en) Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor.
ITTO930610A0 (en) COMPOSITION BASED ON 1,1,1,3,3,-PENTAFLUOROBUTANE AND METHYLENE CHLORIDE FOR CLEANING AND/OR DRYING OF SOLID SURFACES.
DZ2937A1 (en) New compositions of insulin sensitizers.
FR2714674B1 (en) Hydrotropic agents and compositions containing them.
IT232233Y1 (en) MACHINE FOR THE MANAGEMENT OF SERVICES, IN PARTICULAR GAMES AND RELATED INFORMATION.
DE9308446U1 (en) BUSINESS CARD
KR940026478U (en) Business card
DE29718032U1 (en) Business card
KR960004331U (en) Business card case
KR950022994U (en) Business card case
ITFI930019A0 (en) (1S)-2-DETHYLAMINO-1-METHYLETHYL (1S,2S)-CIS-1-HYDROXY-(1,1'BICICLIOHEXYL)-2-CARBOXY-SIDE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
IT1294580B1 (en) CUSTOMIZING MACHINE OF CARDS AND PLATES.
ES1037965Y (en) "BUSINESS CARD, PERFECTED".
TH31470A (en) The pirol that was replaced
ES1037082Y (en) "PERFECTED PORTABLE EXHIBITOR".
IT232152Y1 (en) INTEGRATED WORKSTATION FOR TELEPHONE INFORMATION SERVICES OPERATOR.
KR940019965U (en) Business card